IP Verse

Methods Of Increasing Endogenous Erythropoietin (Epo)

Patent No. EP2324834 (titled "Methods Of Increasing Endogenous Erythropoietin (Epo)") was filed by Fibrogen on Dec 6, 2002. The application was issued on May 8, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AKEBIA THERAPEUTICSFeb 10, 2020JONES DAY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2324834

FIBROGEN
Application Number
EP10181843A
Filing Date
Dec 6, 2002
Status
Revoked
Feb 11, 2022
Publication Date
May 8, 2019
External Links
Slate, Register , Google Patents